Citigroup’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $44.9M | Buy |
|
|||||
|
2023
Q3 | $6.23M | Buy |
|
|||||
|
2023
Q2 | $4.18M | Sell |
|
|||||
|
2023
Q1 | $6.07M | Buy |
|
|||||
|
2022
Q4 | $3.86M | Sell |
|
|||||
|
2022
Q3 | $6.11M | Sell |
|
|||||
|
2022
Q2 | $5.08M | Buy |
|
|||||
|
2022
Q1 | $1.31M | Sell |
|
|||||
|
2021
Q4 | $9.42M | Buy |
|
|||||
|
2021
Q3 | $2.72M | Sell |
|
|||||
|
2021
Q2 | $3.93M | Sell |
|
|||||
|
2021
Q1 | $4.57M | Buy |
|
|||||
|
2020
Q4 | $992K | Buy |
|
|||||
|
2020
Q3 | $653K | Sell |
|
|||||
|
2020
Q2 | $2.37M | Buy |
|
|||||
|
2020
Q1 | $763K | Buy |
|
|||||
|
2019
Q4 | $331K | Buy |
|
|||||
|
2019
Q3 | $3K | Sell |
|
|||||
|
2019
Q2 | $230K | Buy |
|